Maintenance or consolidation therapy for non–small-cell lung cancer: a meta-analysis involving 5841 subjects
C Zhang, C Huang, J Wang, X Wang, K Li - Clinical Lung Cancer, 2015 - Elsevier
Introduction Maintenance therapy is a new treatment paradigm for advanced non–small-cell
lung cancer (NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in …
lung cancer (NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in …
Maintenance or Consolidation Therapy for Non–Small-Cell Lung Cancer: A Meta-Analysis Involving 5841 Subjects
C Zhang, C Huang, J Wang, X Wang… - Clinical Lung …, 2015 - clinical-lung-cancer.com
Introduction Maintenance therapy is a new treatment paradigm for advanced non–small-cell
lung cancer (NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in …
lung cancer (NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in …
Maintenance or Consolidation Therapy for Non--Small-Cell Lung Cancer: A Meta-Analysis Involving 5841 Subjects.
C Zhang, C Huang, J Wang, X Wang, K Li - Clinical Lung Cancer, 2015 - europepmc.org
Materials and methods Electronic databases were obtained from published reports of
randomized controlled trials (RCTs) that compared maintenance or consolidation therapy …
randomized controlled trials (RCTs) that compared maintenance or consolidation therapy …
Maintenance or Consolidation Therapy for Non–Small-Cell Lung Cancer: A Meta-Analysis Involving 5841 Subjects
C Zhang, C Huang, J Wang, X Wang, K Li - Clinical Lung Cancer, 2015 - infona.pl
Maintenance therapy is a new treatment paradigm for advanced non–small-cell lung cancer
(NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in NSCLC and …
(NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in NSCLC and …
Maintenance or Consolidation Therapy for Non--Small-Cell Lung Cancer: A Meta-Analysis Involving 5841 Subjects
C Zhang, C Huang, J Wang, X Wang… - Clinical lung …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction Maintenance therapy is a new treatment paradigm for advanced non-small-cell
lung cancer (NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in …
lung cancer (NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in …